Rifabutin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the prevention of disseminated Mycobacterium avium complex (MAC) infection in people with advanced HIV infection. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Rifabutina and Mycobutin. Its PubChem CID is 135415564.
Rifabutin
| CAS No | 72559-06-9 |
|---|---|
| Molecular Formula | C46H62N4O11 |
| Molecular Weight | 847.0 g/mol |
| Synonyms | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the prevention of disseminated Mycobacterium avium complex (MAC) infection in people with advanced HIV infection. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars.
The listed CAS number is 72559-06-9.
The listed molecular formula is C46H62N4O11.
The listed molecular weight is 847.0 g/mol.
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate.
The source lists Rifabutina and Mycobutin.